Estados financieros detallados de Skye Bioscience, Inc. (SKYE): cuenta de resultados, balance general y flujo de caja. Sigue la evolución de márgenes, deuda, liquidez y rentabilidad año a año con hasta 20 años de histórico.
Resumen del Análisis
Márgenes de los últimos 12 meses: margen bruto 0.0%, margen operativo 0.0%, margen neto 0.0%.
Al precio actual de $1.70, SKYE presenta beneficios negativos (P/E no significativo) y un ROE del -279.29%. La capitalización bursátil es de $7M.
Cuenta de Resultados (10 años)
| Año | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|
| Ingresos | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Coste de Ventas | $14916 | $8038 | $1544 | $1462 | $1872 | 0 | 0 | 0 | 0 | $723352 |
| Beneficio Bruto | -$14916 | -$8038 | -$1544 | -$1462 | -$1872 | 0 | 0 | 0 | 0 | -$723352 |
| I+D | $939040 | $311302 | $329966 | $2.2M | $1.9M | $2.9M | $6.0M | $5.8M | $18.7M | $42.4M |
| Generales y Administrativos | $3.5M | $3.5M | $4.4M | $4.4M | $4.3M | $4.9M | $6.1M | $7.9M | $17.7M | $15.8M |
| Gastos Operativos | $4.5M | $3.9M | $4.7M | $6.6M | $6.3M | $7.8M | $18.3M | $34.7M | $30.2M | $57.4M |
| Beneficio Operativo | -$4.5M | -$3.9M | -$4.7M | -$6.6M | -$6.3M | -$7.8M | -$18.3M | -$34.7M | -$30.2M | -$58.2M |
| EBITDA | 0 | -$3.1M | -$4.7M | $2.0M | -$5.9M | -$7.7M | -$18.7M | -$36.6M | -$25.3M | -$55.2M |
| Gastos por Intereses | 0 | $667 | $94763 | $1.0M | $706385 | $767511 | $663774 | $906270 | $967602 | 0 |
| Beneficio Antes de Impuestos | -$3.2M | -$3.1M | -$19.2M | $1.1M | -$6.6M | -$8.5M | -$19.5M | -$37.6M | -$26.6M | -$55.9M |
| Impuestos | $1600 | $1600 | $1642 | $1600 | $1600 | $2100 | $6741 | $3600 | $10071 | $5400 |
| Beneficio Neto | -$3.2M | -$3.1M | -$19.2M | $1.1M | -$6.6M | -$8.5M | -$19.5M | -$37.6M | -$26.6M | -$55.9M |
| BPA | $-335.44 | $-204.96 | $-292.08 | $15.84 | $-56.88 | $-40.00 | $-70.16 | $-42.96 | $-5.84 | $-11.28 |
| BPA Diluido | $-319.20 | $-204.96 | $-292.08 | $15.84 | $-59.68 | $-40.00 | $-70.16 | $-42.96 | $-5.84 | $-11.28 |
| Acciones en Circulación (Diluidas) | $9957 | $15096 | $65723 | $66501 | $115710 | $203300 | $277635 | $875750 | $4.6M | $5.0M |
Cuenta de Resultados (Trimestral)
| Año | 2025-Q3 | 2025-Q4 | 2026-Q1 | 2026-Q2 |
|---|
| Ingresos | 0 | 0 | 0 | 0 |
| Beneficio Bruto | 0 | 0 | -$172886 | 0 |
| Beneficio Operativo | -$13.3M | -$14.9M | -$12.7M | -$11.1M |
| EBITDA | -$12.6M | -$14.3M | -$12.3M | -$10.8M |
| Beneficio Neto | -$12.8M | -$14.4M | -$12.5M | -$10.8M |
| BPA | $-2.56 | $-2.88 | $-2.56 | $-2.16 |
| BPA Diluido | $-2.56 | $-2.88 | $-2.56 | $-2.16 |
Balance (10 años)
| Año | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|
| Caja y Equivalentes | $64820 | $259955 | $1.9M | $1.8M | $2.5M | $9.0M | $1.2M | $1.3M | $68.4M | $5.9M |
| Inversiones a Corto | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | $19.9M |
| Cuentas por Cobrar | 0 | 0 | 0 | 0 | 0 | 0 | $74121 | $158242 | $5065 | $10474 |
| Inventario | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Activos Corrientes | $279489 | $555811 | $2.0M | $2.0M | $2.7M | $9.6M | $8.9M | $11.7M | $70.8M | $27.1M |
| Inmovilizado Material | $9584 | $1407 | $3445 | $1983 | $7341 | $234682 | $159045 | $281259 | $1.9M | $1.2M |
| Fondo de Comercio | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Activos Intangibles | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Activos Totales | $323363 | $557218 | $2.0M | $2.0M | $2.7M | $9.9M | $9.1M | $11.9M | $72.8M | $28.3M |
| Cuentas por Pagar | $274650 | $100921 | $15597 | $139809 | $381372 | $900010 | $1.8M | $956754 | $569252 | $2.0M |
| Deuda a Corto | 0 | $235000 | 0 | 0 | $64062 | $2.0M | $1.9M | $4.4M | 0 | 0 |
| Pasivos Corrientes | $661958 | $805974 | $15.9M | $970818 | $787199 | $3.9M | $12.1M | $13.9M | $4.3M | $8.2M |
| Deuda a Largo | 0 | 0 | $1.4M | $387070 | $1.4M | 0 | 0 | 0 | 0 | $83999 |
| Pasivos Totales | $1.8M | $1.4M | $17.5M | $1.4M | $2.2M | $4.0M | $12.1M | $14.1M | $4.6M | $8.3M |
| Reservas | -$10.9M | -$14.0M | -$33.2M | -$32.2M | -$38.7M | -$47.3M | -$66.7M | -$104.4M | -$130.9M | -$186.9M |
| Patrimonio Neto | -$1.5M | -$800078 | -$15.6M | $548058 | $450786 | $5.9M | -$3.0M | -$2.1M | $68.2M | $20.0M |
| Deuda Total | 0 | $235000 | $1.4M | $387070 | $1.5M | $2.1M | $2.0M | $4.6M | $455590 | $273646 |
| Deuda Neta | -$64820 | -$24955 | -$492413 | -$1.4M | -$971607 | -$6.8M | $737999 | $3.4M | -$68.0M | -$25.5M |
| Capital Circulante | -$382469 | -$250163 | -$14.0M | $1.0M | $1.9M | $5.7M | -$3.2M | -$2.3M | $66.5M | $18.9M |
Balance (Trimestral)
| Año | 2025-Q3 | 2025-Q4 | 2026-Q1 | 2026-Q2 |
|---|
| Caja y Equivalentes | $18.4M | $5.9M | $8.1M | $8.1M |
| Activos Totales | $41.3M | $28.3M | $19.4M | $11.0M |
| Pasivos Totales | $8.5M | $8.3M | $10.4M | $11.5M |
| Patrimonio Neto | $32.8M | $20.0M | $9.0M | -$497307 |
| Deuda Total | $321845 | $273646 | $311318 | $35696 |
Flujo de Caja (10 años)
| Año | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|
| Beneficio Neto | -$3.2M | -$3.1M | -$19.2M | $1.1M | -$6.6M | -$8.5M | -$19.5M | -$37.6M | -$26.6M | -$55.9M |
| Amortizaciones | $14916 | $8039 | $1544 | $1462 | $1872 | $34131 | $114998 | $124251 | $298640 | $723352 |
| Compensación en Acciones | $706368 | $608676 | $674961 | $680455 | $302742 | $869206 | $629032 | $987510 | $8.3M | $7.8M |
| Cambio en Capital Circulante | $40517 | -$323846 | $100192 | $295714 | $94191 | $646943 | -$761904 | -$469307 | -$2.6M | $4.7M |
| Flujo de Caja Operativo | -$3.6M | -$3.3M | -$3.9M | -$6.0M | -$6.1M | -$6.5M | -$12.7M | -$14.0M | -$25.2M | -$43.1M |
| Inversiones (CapEx) | -$11117 | -$19654 | -$4385 | 0 | -$7230 | -$90866 | -$28060 | -$12550 | -$1.6M | -$6312 |
| Adquisiciones | 0 | 0 | 0 | 0 | 0 | 0 | $5.3M | 0 | 0 | 0 |
| Recompra de Acciones | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Dividendos Pagados | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Flujo de Caja Libre | -$3.6M | -$3.3M | -$3.9M | -$6.0M | -$6.1M | -$6.6M | -$12.8M | -$14.0M | -$26.8M | -$43.1M |
Flujo de Caja (Trimestral)
| Año | 2025-Q3 | 2025-Q4 | 2026-Q1 | 2026-Q2 |
|---|
| Flujo de Caja Operativo | -$13.4M | -$9.8M | -$8.6M | -$7.1M |
| Inversiones (CapEx) | -$5 | -$3 | -$3 | 0 |
| Flujo de Caja Libre | -$13.4M | -$9.8M | -$8.6M | -$7.1M |
| Dividendos Pagados | 0 | 0 | 0 | 0 |
| Compensación en Acciones | $1.9M | -$2.20B | $1.5M | $1.3M |
Crecimiento y Márgenes (10 años)
| Año | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|
| Crecimiento Beneficio Neto (anual) | | +2.6% | -520.4% | +105.5% | -723.7% | -29.9% | -128.6% | -93.2% | +29.4% | -110.5% |
| Crecimiento BPA (anual) | | +38.9% | -42.5% | +105.4% | -459.1% | +29.7% | -75.4% | +38.8% | +86.4% | -93.2% |
| Cambio en Acciones (anual) | | +51.6% | +335.4% | +1.2% | +74.0% | +75.7% | +36.6% | +215.4% | +420.8% | +8.7% |
| Crecimiento FCF (anual) | | +6.9% | -19.0% | -52.7% | -0.6% | -8.3% | -94.5% | -9.3% | -92.2% | -60.5% |
| Tasa Impositiva Efectiva | -0.1% | -0.1% | -0.0% | 0.2% | -0.0% | -0.0% | -0.0% | -0.0% | -0.0% | -0.0% |
Datos por Acción (10 años)
| Año | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|
| FCF por Acción | $-357.94 | $-219.78 | $-60.06 | $-90.64 | $-52.38 | $-32.30 | $-46.00 | $-15.95 | $-5.89 | $-8.69 |
| Dividendo por Acción | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Acciones en Circulación (Básicas) | $9474 | $15096 | $65723 | $66501 | $115373 | $203300 | $277635 | $875750 | $4.6M | $5.0M |
Qué mirar en Biotech
La mayoría de biotechs pequeñas pierden dinero. Analizarlas con P/E no tiene sentido — mira caja y pipeline.
- Cash Runway — Meses de caja al ritmo de gasto actual. <18 meses = riesgo de dilución urgente
- Cash burn anual — Ritmo al que queman caja operativa. Comparar con posición de caja para proyectar runway
- Total Debt — Biotech sin ingresos + deuda = receta para bancarrota
- I+D / Capitalización — Cuánto invierten en pipeline vs lo que vale la empresa — indicador de intensidad investigadora
- Market cap / Cash — Si cotiza cerca de su caja, el mercado le da ~0 valor al pipeline — puede ser oportunidad o trampa
Rentabilidad
| Rentabilidad sobre capital | -279.29% |
| Rentabilidad sobre capital invertido | -286.55% |
| Rentabilidad sobre activos | -197.52% |
| Margen bruto | 0.00% |
| Margen operativo | 0.00% |
| Margen neto | 0.00% |
Salud financiera
| Deuda / Patrimonio | 0.01 |
| Ratio corriente | 3.30 |
Ratios Clave (10 años)
| Año | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|
| P/E | -1.80 | -1.48 | -2.74 | 16.54 | -1.41 | -2.60 | -0.46 | -0.51 | -3.88 | -0.53 |
| P/VC | -3.94 | -5.74 | -3.38 | 31.79 | 20.47 | 3.61 | -2.95 | -8.94 | 1.52 | 1.49 |
| P/V | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Margen Bruto | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Margen Operativo | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Margen Neto | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |